|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A01K 67/027 | (2006.01) |
| G01N 33/50 | (2006.01) | ||
| C07K 14/705 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 14/47 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3466255 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18207075.5 |
| Date of filing the European patent application | 2015-11-25 | |
| (97) | Date of publication of the European application | 2019-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2021-02-17 |
| (46) | Date of publication of the claims translation | 2021-05-25 |
| (30) | Number | Date | Country code |
| 201462087992 P | 2014-12-05 | US |
| (72) |
GURER, Cagan, US
IOFFE, Ella, US
MUJICA, Alexander, US
THURSTON, Gavin, US
|
| (73) |
REGENERON PHARMACEUTICALS, INC.,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Gyvūnai, išskyrus žmogų, turintys humanizuotą diferenciacijos klasterio 47 geną |
| NON-HUMAN ANIMALS HAVING A HUMANIZED CLUSTER OF DIFFERENTIATION 47 GENE |
| Payment date | Validity (years) | Amount | |
| 2024-10-22 | 10 | 231.00 EUR |
| 2025-11-25 |